ARTICLE | Strategy
Networked in China
How small biotechs Ligand, Harbor BioSciences found partners in China
February 7, 2011 8:00 AM UTC
Recent China-focused deals by Ligand Pharmaceuticals Inc. and Harbor BioSciences Inc. provide a roadmap for small biotechs looking to execute a China strategy. The key is personal networking.
In January, Ligand granted Chiva Pharmaceuticals Inc. rights to develop and commercialize HBV candidate pradefovir and liver cancer candidate MB01733 in China. Pradefovir has completed Phase II studies while MB01733 has completed a Phase I/II trial in the U.S...